Harvard faculty, students, researchers, and staff are working alongside hospitals, first responders, state and city leaders, and many more across Greater Boston to support the response to the coronavirus pandemic. The Gazette recently spoke with some professors and administrators about the research, projects, and collaborations the University has undertaken amid the unprecedented global health crisis.
GAZETTE: Many people are aware of the front-line care being provided by Harvard teaching hospitals and the work on diagnostics,...
During a pandemic, a lot of things come to a halt, but one thing that never ceases is our need for a reliable supply of safe, nutritious food. Harvard Law School Professor Emily Broad Leib, J.D. ’08, director of the HLS Food Law and Policy Clinic (FLPC), and her students have been working furiously to ensure that the most vulnerable — and ultimately the rest of us — are fed.
Broad Leib and the clinic have long been a resource for food producers, food-...
This article is part of Harvard Medical School’s continuing coverage of medicine, biomedical research, medical education and policy stories related to the SARS-CoV-2 pandemic and the disease COVID-19.
From the plagues of medieval Europe to the influenza pandemic of 1918, the specter of the next public health disaster has gripped the minds of scientists, captivated the imaginations of writers and vexed conspiracy theorists.
Now, a new coronavirus is engulfing the world, and the long-foretold ...
This is part of our Coronavirus Update series in which Harvard specialists in epidemiology, infectious disease, economics, politics, and other disciplines offer insights into what the latest developments in the COVID-19 outbreak may bring.
As Massachusetts rapidly ramps up COVID-19 testing, a technology born in the lab of Harvard AIDS pioneer Max Essex and nurtured by entrepreneurship resources on campus has...
Editor’s Note: Enrollment in the PATHFINDER study is temporarily suspended due to the COVID-19 pandemic.
In a study involving thousands of participants, a new blood test detected more than 50 types of cancer as well as their location within the body with a high degree of accuracy, according to an international team of researchers led by Dana-Farber Cancer Institute, a Harvard affiliate, and the Mayo Clinic.
This is part of our Coronavirus Update series in which Harvard specialists in epidemiology, infectious disease, economics, politics, and other disciplines offer insights into what the latest developments in the COVID-19 outbreak may bring.
With global coronavirus cases heading toward half a million, Harvard infectious disease experts said recent modeling shows that — absent the development of a vaccine or other intervention — a staggered pattern of social distancing...
This semester, Matt Saunders launched the biggest studio art class at Harvard. The class of 72 students in “Painting’s Doubt” met weekly to learn figure drawing and paint from still life. When the coronavirus outbreak forced Saunders to move the class online, he faced some fundamental problems.
“We lose a lot of the value of having students all together because an important part of learning in this class happens through the peer group,” said Saunders. For the first half of the semester, he framed each session and gave pointers about how to approach rendering the subject, but “students [...
Many basic and clinical researchers are testing the potential of a simple and efficient gene editing approach to study and correct disease-causing mutations for conditions ranging from blindness to cancer, but the technology is constrained by a requirement that a certain short DNA sequence be present at the gene editing site.
Now investigators at Massachusetts General Hospital (MGH) have modified the system to be nearly free of this requirement, making it possible to potentially target any location across the entire human genome. Their advance is described in Science.
This is part of our Coronavirus Update series in which Harvard specialists in epidemiology, infectious disease, economics, politics, and other disciplines offer insights into what the latest developments in the COVID-19 outbreak may bring.
With more than 50,000 patients admitted annually and millions of outpatient visits each year, Massachusetts General Hospital (MGH), one of the nation’s premier hospitals and biomedical research facilities, is an extremely busy place...
This is part of our Coronavirus Update series in which Harvard specialists in epidemiology, infectious disease, economics, politics, and other disciplines offer insights into what the latest developments in the COVID-19 outbreak may bring.
A Harvard public health professor warned Tuesday that the COVID-19 outbreak in the U.S. could rank among the world’s worst if the nation fails to take steps to ease the health and economic impacts on America’s poor, who face...
